Clinical Assessment and Treatment in the Nursing Home as an Alternative to Hospital Admission
Home-Based Assessment and Treatment by Municipal Acute Care Teams Combined With Remote Senior Physician Consultation as an Alternative to Hospital Admission for Nursing Home Residents: A Multicenter Randomized Controlled Trial
調査の概要
詳細な説明
Background and Rationale:
Nursing home residents represent one of the most vulnerable populations in the healthcare system. Most residents are older adults with multiple chronic conditions, frailty, reduced functional capacity, and a high risk of adverse outcomes associated with hospitalization. Hospital admissions may lead to complications such as delirium, hospital-acquired infections, functional decline, and reduced quality of life.
In Denmark, all nursing home residents are registered with a general practitioner, who is responsible for addressing medical issues requiring physician assessment during regular office hours (Monday through Friday 08:00-16:00). During out-of-hours periods, nursing home staff often have limited access to medical assessment and decision support. Municipal acute care teams, staffed by experienced nurses, possess substantial clinical competencies; however, access to physician consultation is often limited during evenings, weekends, and public holidays. Consequently, nursing home residents may be referred to an emergency department or admitted to hospital in situations where clinical assessment and treatment within the nursing home could potentially represent a safe and appropriate alternative.
This study evaluates a new cross-sector care model developed through collaboration between municipalities, municipal acute care teams and hospitals in the Capital Region of Denmark. The model combines home-based clinical assessment by municipal acute care teams with remote consultations with senior physicians from the emergency or geriatrics department. The overall aim is to improve access to timely clinical decision-making, provide treatment in familiar surroundings whenever appropriate, and reduce potentially avoidable hospital admissions.
Study Design:
This is a multicenter, cluster-randomized, unblinded quality-improvement study conducted among nursing homes in the Capital Region of Denmark. Nursing homes are randomized to either the intervention pathway or usual care.
The intervention is implemented during out-of-hours periods, defined as weekdays between 16:00 and 22:00 and weekends and public holidays between 08:00 and 22:00. During these periods, participating intervention nursing homes follow the study pathway, whereas control nursing homes continue standard practice. During regular office hours (Monday through Friday 08:00-16:00) both groups contact the general practitioner as usual, and during nights (22:00-08:00), both groups contact the regional medical helpline, 1813.
Before contacting external healthcare services, nursing home staff in both groups always perform an initial assessment including measurement of vital signs and evaluation of the resident's clinical condition. Residents with immediately life-threatening conditions continue to be managed through standard emergency medical services (112).
The study includes an initial run-in period (1 February-1 September 2026) to optimize implementation of the intervention. Following the run-in period, a new cluster randomization with an increased number of intervention nursing homes will be performed before the start of the main data collection.
Intervention (Home-Based Care Program):
Nursing homes randomized to the intervention arm will, whenever a resident requires urgent clinical assessment during out-of-hours periods, call the municipal acute care team directly instead of the regional medical helpline (1813). The acute care team may manage and conclude the case directly by phone, or they may conduct an on-site comprehensive clinical assessment first. When physician input is required, the acute care team consults a senior physician from the emergency or geriatrics department by telephone or video conference.
Following this remote consultation, a treatment and/or observation plan is established. Possible outcomes of include:
- Management and discharge at the nursing home with advice and minor interventions.
- Follow-up by the resident's general practitioner on the next working day.
- Home-based treatment under hospital responsibility with planned follow-up from the municipal acute care team (Hospital-at-Home, HaH).
- Subacute outpatient assessment at the hospital.
- Assessment by a mobile physician service.
- Acute hospital admission when clinically indicated.
Control Group:
Nursing homes in the control group will follow standard care when a resident experiences acute illness or clinical deterioration during out-of-hours periods, that is, call the regional medical helpline, 1813.
Data Collection and Analysis:
Data on the primary outcomes will be collected by physicians employed at Copenhagen University Hospital - Herlev and Gentofte. Data on disposition following the initial assessment will be recorded by nurses from the municipal acute care teams and subsequently collected by the study physicians. Statistical analyses will be performed by the study physicians in collaboration with a biostatistician from the University of Copenhagen. The study findings will be submitted for publication in peer-reviewed scientific journals.
Sample Size and Run-in Period:
This is a pragmatic quality-improvement study. All municipalities in the Capital Region of Denmark, with the exception of Bornholm, have been invited to participate, and all nursing homes within participating municipalities are eligible for inclusion. Consequently, the final sample size will depend on the number of participating municipalities and nursing homes during the study period. Although the study is ongoing, data collection for the main analyses has not yet commenced. A statistical power calculation based on the expected sample size will therefore be performed before initiation of the primary data collection to estimate the study's power to detect clinically relevant differences in the primary outcomes.
An initial run-in period was conducted from 1 February to 1 September 2026 to evaluate and optimize implementation of the intervention. Following this period, a new cluster randomization with an increased number of intervention nursing homes will be performed before commencement of the main study period.
Ethical Considerations:
The study is classified as a quality-improvement initiative and therefore does not require approval from the National Committee on Health Research Ethics. It has been approved by the regional research governance office of the Capital Region of Denmark (P-2026-21209).
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前:Josephine L Nielsen, MD
- 電話番号:+4527156091
- メール:josephine.lund.nielsen@regionh.dk
研究連絡先のバックアップ
- 名前:Maria N Larsen, MD, PhD
- 電話番号:+4540314282
- メール:maria.normand.larsen@regionh.dk
研究場所
-
-
-
Copenhagen、デンマーク
- 募集
- Copenhagen University Hospital - Bispebjerg and Frederiksb
-
Herlev、デンマーク
- 募集
- University Hospital of Copenhagen Herlev
-
Hillerød、デンマーク
- 募集
- Copenhagen University Hospital - North Zealand Hospital
-
Hvidovre、デンマーク
- 募集
- University Hospital of Copenhagen Amager and Hvidovre
-
-
参加基準
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
説明
Clusters (Nursing Homes):
Inclusion Criteria:
- Nursing homes, defined as long-term care facilities with care personnal available 24/7 for residents with need for continued medical care
- Nursing homes located in the Capital Region of Denmark
- Nursing homes accepting participation and cluster randomization
Exclusion criteria
- Assisted living facilities, intermediate/temporary care units, rehabilitation units, hospices, or other non-nursing-home setting.
- Nursing homes located on the island of Bornholm
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:ヘルスサービス研究
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
介入なし:標準治療
対照群
|
|
|
実験的:Home-based assessment and treatment
The intervention group
|
Nursing homes in the intervention group will, if a resident experiences acute illness or clinical deterioration, call the municipal acute care team directly.
They will then do a home-based clinical assessment and, if deemed necessary, consult a senior physician in the hospital emergency or geriatrics department to establish a treatment and observation plan.
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Time to first event
時間枠:From date of randomization until the date of first event, up to 7 months.
|
Time to first event defined as either "acute hospital admission" or "death from any cause", compared between intervention and usual care groups using time-to-event methods, with superiority testing.
|
From date of randomization until the date of first event, up to 7 months.
|
|
All-cause mortality
時間枠:From date of randomization until date of death from any cause, up to 7 months
|
Time to death from any cause, compared between intervention and usual care groups using time-to-event methods, with non-inferiority testing.
|
From date of randomization until date of death from any cause, up to 7 months
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Initial Disposition After Assessment by the Municipal Acute Care Team
時間枠:At completion of the index assessment, up to 6 hours.
|
Distribution of contacts according to the immediate disposition following assessment by the municipal acute care team. Disposition categories include:
|
At completion of the index assessment, up to 6 hours.
|
|
Number of emergency contacts (both groups)
時間枠:From date of randomization until the end of follow-up, up to 48 weeks.
|
Number of contacts to 1813 or the municipal acute care team, respectively, during follow-up period.
|
From date of randomization until the end of follow-up, up to 48 weeks.
|
|
Total healthcare cost per nursing home resident
時間枠:From date of randomization until the end of follow-up, up to 48 weeks.
|
Economic evaluation comparing the intervention and control groups based on the mean total cost per nursing home resident (DKK) during the follow-up period. Multiple resource measures will be collected. These include:
|
From date of randomization until the end of follow-up, up to 48 weeks.
|
|
Proportion of in-hospital deaths
時間枠:From date of randomization until date of death from any cause, up to 7 months
|
Proportion of in-hospital deaths out of all deseased nursing home residents in both the intervention and the control group.
|
From date of randomization until date of death from any cause, up to 7 months
|
|
Proportion of end-of-life hospitalizations
時間枠:From date of randomization until date of death from any cause, up to 7 months
|
Proportion of end-of-life hospitalizations, defined as hospitalizations during the last month before death, out of total number of deseased nursing home residents.
|
From date of randomization until date of death from any cause, up to 7 months
|
その他の成果指標
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Nursing home resident experience (qualitative)
時間枠:One month after clinical assessment
|
Evaluation through semi-structured interviews
|
One month after clinical assessment
|
|
Healthcare personal experience (qualitative)
時間枠:6 months after enrollment of nursing home
|
Evaluation through semi-structured interviews
|
6 months after enrollment of nursing home
|
協力者と研究者
捜査官
- スタディチェア:Kasper K Iversen, MD, Professor、University Hospital of Copenhagen Herlev and Gentofte
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
- Hospital in the Nursing Home
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。